文献速递血液净化与透析

碳酸氢钠封管液减少血透导管丢失:开放标签临床试验

Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

该开放标签临床试验在纽约布鲁克林社区医院纳入451例经中心静脉导管接受血透的成人患者,比较碳酸氢钠封管液(SBCLS)与生理盐水封管液(NSCLS)对导管相关血栓(CRT)和血流感染(CRBSI)所致导管丢失的影响。结果显示SBCLS组CRT和CRBSI发生率均为0.17/1000导管日,显著低于NSCLS组,且SBCLS安全。

要点

  • SBCLS组CRT和CRBSI发生率均为0.17/1000导管日
  • NSCLS组CRT发生率4.1/1000导管日,CRBSI发生率2.6/1000导管日
  • SBCLS显著降低CRT(P<0.0001)和CRBSI(P=0.0004)所致导管丢失

核心结论

  • 碳酸氢钠封管液安全且统计学上优于生理盐水,可预防血透导管因CRT和CRBSI丢失。

研究设计与样本

  • 开放标签临床试验,在美国布鲁克林社区医院纳入451例≥18岁经中心静脉导管接受血透的成人患者,随访546天。

主要发现

  • NSCLS组CRT发生率4.1/1000导管日,CRBSI发生率2.6/1000导管日;SBCLS组两者均为0.17/1000导管日。
  • SBCLS组因CRT(P<0.0001)和CRBSI(P=0.0004)所致导管丢失率显著降低。
  • NSCLS组导管丢失风险更高:CRT的OR为26.6(95%CI 3.57-198.52),CRBSI的OR为15.9(95%CI 2.09-121.61)。

关键数值与推荐

  • SBCLS组CRT和CRBSI发生率均为0.17/1000导管日。
  • NSCLS组CRT发生率4.1/1000导管日,CRBSI发生率2.6/1000导管日。
  • CRT所致导管丢失比较P<0.0001,CRBSI比较P=0.0004。

临床怎么用

  • 碳酸氢钠封管液价格低廉、易得,可考虑用于预防血透导管因CRT和CRBSI丢失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no ideal lock solution that prevents hemodialysis (HD) catheter loss due to catheter-related thrombosis (CRT) and catheter-related bloodstream infection (CRBSI). Catheter loss is associated with increased hospitalization and high inpatient costs. Sodium bicarbonate (NaHCO3) demonstrates anti-infective and anticoagulation properties with a good safety profile, making it an ideal lock solution development target.The objective of this study was to determine the safety and efficacy of using sodium bicarbonate catheter lock solution (SBCLS) as a means of preventing HD catheter loss due to CRT and CRBSI. METHODS: The study took place in a community hospital in Brooklyn, NY, USA. All admitted patients ≥18 years of age who needed HD treatment through CVC were included in the study. 451 patients included in the study were provided SBCLS or NSCLS post-dialysis. Catheter loss due to CRT or CRBSI was evaluated over a period of 546 days. RESULTS: A total of 452 patients met the criteria; 1 outlier was excluded, 226 were in the NSCLS group and 225 were in the SBCLS group. There were no significant differences between groups in comorbidities at the outset. The NSCLS group had CRT and CRBSI rates of 4.1 and 2.6/1000 catheter days (CD), respectively, compared with 0.17/1000 CD for both outcomes in the SBCLS group. SBCLS patients had a significantly reduced catheter loss rate due to CRT (P < 0.0001) and CRBSI (P = 0.0004). NSCLS patients had higher odds of losing their catheter due to CRT {odds ratio [OR] 26.6 [95% confidence interval (CI) 3.57-198.52]} and CRBSI [OR 15.9 (95% CI 2.09-121.61)] during the study period. CONCLUSION: The novel approach of using SBCLS was found to be safe and was statistically superior to normal saline in preventing HD catheter loss due to CRT and CRBSI. NaHCO3 solution is inexpensive, readily available in various settings and holds the potential to decrease hospitalization, length of stay and dialysis-related costs. TRIAL REGISTRATION: Maimonides Medical Center Investigational Review Board, Study IRB 2015-06-25-CIH. ClinicalTrials.gov identifier: NCT03627884.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. El-Hennawy AS, Frolova E, Romney WA, et al. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial. Nephrol Dial Transplant. 2019. PMID: 30668833. doi:10.1093/ndt/gfy388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。